Cannabinoids do not seem to be equally effective in the treatment of all pain conditions in humans. Cannabinoids are not effective against acute pain. Cannabinoids may only modestly reduce chronic pain. CBD in combination with THC is recommended by the European Federation of Neurological Societies as a second or third-line treatment for central pain in multiple sclerosis, and by Canadian experts as a third-line agent for neuropathic pain
https://ipsnews.net/business/2021/12/18/green-galaxy-cbd-gummies-reviews...